DAWN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.70%

Insider Buying (Last 12 Months): $29,500,005.00

Insider Selling (Last 12 Months): $30,203,726.65

Day One Biopharmaceuticals Insider Trading History Chart

Day One Biopharmaceuticals Share Price & Price History

^$21.45

▼ -0.09 (-0.42%)

As of 01/27/2023 01:00 AM ET

Days: 30 | 90 | 365

Is This The End of Capitalism?

From Porter & Company | Ad

EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…

click here now to get all the chilling details.

Day One Biopharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/23/2023	Jeremy Bender	CEO	Sell	12,500	$22.00	$275,000.00	1,181,486
1/20/2023	Charles N York II	CFO	Sell	10,000	$22.75	$227,500.00	268,810
1/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$22.86	$228,600.00	1,250,148
1/3/2023	Julie Papanek Grant	Director	Sell	25,000	$20.65	$516,250.00	380,000
12/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.32	$254,000.00	1,192,424
12/20/2022	Charles N York II	CFO	Sell	10,000	$20.07	$200,700.00	276,497
12/8/2022	Julie Papanek Grant	Director	Sell	4,358	$22.08	$96,224.64	405,000
12/1/2022	Julie Papanek Grant	Director	Sell	5,000	$21.75	$108,750.00	414,358
12/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$21.45	$214,500.00	1,260,148
11/21/2022	Charles N York II	CFO	Sell	10,000	$20.76	$207,600.00	286,497
11/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.76	$259,500.00	1,204,924
11/16/2022	Charles N York II	CFO	Sell	430	$21.46	$9,227.80	296,497
11/16/2022	Jeremy Bender	CEO	Sell	1,513	$21.46	$32,468.98	1,217,424
11/16/2022	Samuel C. Blackman	Insider	Sell	377	$21.46	$8,090.42	1,270,148
11/1/2022	Charles N York II	CFO	Sell	10,000	$20.03	$200,300.00	294,401
11/1/2022	Jeremy Bender	CEO	Sell	12,500	$20.03	$250,375.00	1,215,375
11/1/2022	Julie Papanek Grant	Director	Sell	5,000	$20.04	$100,200.00	424,358
10/3/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	304,401
10/3/2022	Jeremy Bender	CEO	Sell	12,500	$20.05	$250,625.00	1,227,875
10/3/2022	Julie Papanek Grant	Director	Sell	5,000	$20.06	$100,300.00	434,358
9/21/2022	Julie Papanek Grant	Director	Sell	613,603	$18.55	$11,382,335.65	8,464,301
9/20/2022	Xi L.P. Canaan	Major Shareholder	Sell	148,670	$19.51	$2,900,551.70	9,077,904
9/19/2022	Julie Papanek Grant	Director	Sell	76,725	$20.57	$1,578,233.25	9,226,574
9/16/2022	Xi L.P. Canaan	Major Shareholder	Sell	115,307	$21.55	$2,484,865.85	9,303,299
9/15/2022	Julie Papanek Grant	Director	Sell	51,281	$22.85	$1,171,770.85	9,418,606
9/14/2022	Xi L.P. Canaan	Major Shareholder	Sell	106,111	$23.68	$2,512,708.48	9,469,887
9/13/2022	Julie Papanek Grant	Director	Sell	87,647	$24.40	$2,138,586.80	9,575,998
9/2/2022	Papanek Julie Grant	Director	Sell	5,000	$23.82	$119,100.00	439,358
8/16/2022	Charles N York II	CFO	Sell	1,089	$24.31	$26,473.59	324,401
8/16/2022	Jeremy Bender	CEO	Sell	4,003	$24.31	$97,312.93	1,252,875
8/16/2022	Samuel C. Blackman	Insider	Sell	941	$24.31	$22,875.71	1,299,338
8/4/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	321,365
8/4/2022	Jeremy Bender	CEO	Sell	12,500	$20.00	$250,000.00	1,246,192
8/4/2022	Papanek Julie Grant	Director	Sell	5,000	$20.00	$100,000.00	454,358
8/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$16.88	$168,800.00	1,296,718
7/18/2022	Charles N York II	CFO	Sell	2,500	$20.00	$50,000.00	331,365
7/18/2022	Papanek Julie Grant	Director	Sell	2,600	$20.00	$52,000.00	459,358
7/8/2022	Charles N York II	CFO	Sell	1,416	$20.00	$28,320.00	333,865
7/8/2022	Jeremy Bender	CEO	Sell	1,795	$20.00	$35,900.00	1,261,292
7/8/2022	Papanek Julie Grant	Director	Sell	1,242	$20.00	$24,840.00	461,958
7/5/2022	Charles N York II	CFO	Sell	800	$20.00	$16,000.00	335,281
7/5/2022	Jeremy Bender	CEO	Sell	857	$20.00	$17,140.00	1,263,087
7/1/2022	Charles N York II	CFO	Sell	1,479	$20.00	$29,580.00	336,081
7/1/2022	Jeremy Bender	CEO	Sell	1,746	$20.00	$34,920.00	1,263,944
7/1/2022	Papanek Julie Grant	Director	Sell	1,000	$20.00	$20,000.00	464,000
7/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$18.72	$187,200.00	1,306,718
6/17/2022	Ai Day1 Llc	Major Shareholder	Buy	1,200,000	$15.00	$18,000,000.00	10,684,638
6/17/2022	Michael Gladstone	Director	Buy	766,667	$15.00	$11,500,005.00	766,667
6/15/2022	Samuel C. Blackman	Insider	Sell	50,000	$16.26	$813,000.00	1,316,718
1/20/2022	Ai Day1 Llc	Major Shareholder	Buy	4,615	$14.73	$67,978.95
1/18/2022	Ai Day1 Llc	Major Shareholder	Buy	43,429	$14.26	$619,297.54
1/3/2022	Samuel C. Blackman	Insider	Sell	10,000	$17.10	$171,000.00
12/8/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	110,338	$18.03	$1,989,394.14
12/6/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	97,692	$18.05	$1,763,340.60
12/3/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	12,517	$18.47	$231,188.99
12/1/2021	Samuel C. Blackman	Insider	Sell	10,000	$17.22	$172,200.00

Is This The End of Capitalism?

From Porter & Company | Ad

EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…

click here now to get all the chilling details.

SEC Filings (Institutional Ownership Changes) for Day One Biopharmaceuticals (NASDAQ:DAWN)

86.08% of Day One Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/8/2022	Bank of New York Mellon Corp	102,223	$2.05M	0.0%	+60.9%	0.139%
11/21/2022	California State Teachers Retirement System	10,929	$0.22M	0.0%	+9.5%	0.015%
11/15/2022	Alliancebernstein L.P.	38,000	$0.76M	0.0%	-10.4%	0.052%
11/15/2022	State Street Corp	2,041,738	$40.90M	0.0%	+469.1%	2.776%
11/15/2022	Tang Capital Management LLC	400,000	$8.01M	1.0%	N/A	0.544%
11/15/2022	Vanguard Group Inc.	2,615,441	$52.39M	0.0%	-0.4%	3.556%
11/15/2022	Price T Rowe Associates Inc. MD	2,094,913	$41.96M	0.0%	+2.6%	2.848%
11/15/2022	Parkman Healthcare Partners LLC	212,191	$4.25M	1.2%	+84.9%	0.288%
11/15/2022	Lord Abbett & CO. LLC	504,251	$10.10M	0.0%	N/A	0.686%
11/15/2022	Laurion Capital Management LP	14,237	$0.29M	0.0%	-5.1%	0.019%
11/15/2022	Bank of New York Mellon Corp	102,223	$2.05M	0.0%	+60.9%	0.139%
11/15/2022	Bayesian Capital Management LP	13,508	$0.27M	0.1%	N/A	0.018%
11/15/2022	BlackRock Inc.	2,541,235	$50.90M	0.0%	+29.5%	3.455%
11/14/2022	Tudor Investment Corp Et Al	36,544	$0.73M	0.0%	N/A	0.050%
11/14/2022	Cubist Systematic Strategies LLC	125,586	$2.52M	0.0%	+105.1%	0.171%
11/14/2022	Renaissance Technologies LLC	97,900	$1.96M	0.0%	-16.1%	0.133%
11/14/2022	Nuveen Asset Management LLC	448,770	$2.97M	0.0%	+518.5%	0.610%
11/14/2022	Parkwood LLC	18,475	$0.37M	0.1%	N/A	0.025%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	54,000	$1.08M	0.0%	N/A	0.073%
11/10/2022	ExodusPoint Capital Management LP	12,903	$0.26M	0.0%	-43.9%	0.018%
11/10/2022	Dimensional Fund Advisors LP	51,408	$1.03M	0.0%	N/A	0.070%
11/10/2022	Tower Research Capital LLC TRC	2,186	$44K	0.0%	-41.7%	0.003%
11/10/2022	UBS Group AG	21,606	$0.43M	0.0%	+461.0%	0.029%
11/9/2022	Amalgamated Bank	3,577	$72K	0.0%	+21.0%	0.005%
11/9/2022	Atlas Venture Life Science Advisors LLC	8,169,171	$163.63M	18.1%	-8.9%	11.120%
11/8/2022	Fisher Asset Management LLC	45,526	$0.91M	0.0%	N/A	0.062%
11/8/2022	New York State Common Retirement Fund	51,790	$1.04M	0.0%	+166.0%	0.071%
11/4/2022	Prudential Financial Inc.	38,315	$0.77M	0.0%	N/A	0.052%
11/3/2022	Barclays PLC	90,429	$1.81M	0.0%	+7,615.8%	0.123%
11/2/2022	Summit Rock Advisors LP	25,751	$0.52M	0.4%	-22.3%	0.035%
10/31/2022	Canaan Partners XI LLC	6,964,301	$139.50M	56.3%	-27.9%	9.480%
8/22/2022	ExodusPoint Capital Management LP	23,003	$0.41M	0.0%	N/A	0.031%
8/18/2022	Goldman Sachs Group Inc.	1,894,537	$33.91M	0.0%	+5,969.9%	2.579%
8/17/2022	Macquarie Group Ltd.	110,000	$1.97M	0.0%	N/A	0.150%
8/16/2022	Utah Retirement Systems	34,184	$0.61M	0.0%	-15.7%	0.047%
8/16/2022	Woodline Partners LP	150,176	$2.69M	0.0%	N/A	0.204%
8/16/2022	Price T Rowe Associates Inc. MD	2,041,344	$36.54M	0.0%	+28.7%	2.779%
8/16/2022	Commodore Capital LP	739,661	$13.24M	2.8%	N/A	1.007%
8/16/2022	Deerfield Management Company L.P. Series C	3,512,123	$62.87M	1.3%	+68.3%	4.781%
8/16/2022	Driehaus Capital Management LLC	501,689	$8.98M	0.1%	+24.3%	0.683%
8/15/2022	Occudo Quantitative Strategies LP	23,619	$0.42M	0.0%	N/A	0.032%
8/15/2022	State Street Corp	358,783	$6.42M	0.0%	+65.9%	0.488%
8/15/2022	Macquarie Group Ltd.	110,000	$1.97M	0.0%	N/A	0.150%
8/15/2022	Cubist Systematic Strategies LLC	61,237	$1.10M	0.0%	N/A	0.083%
8/15/2022	Laurion Capital Management LP	15,000	$0.27M	0.0%	-83.6%	0.020%
8/15/2022	Millennium Management LLC	17,555	$0.31M	0.0%	-90.0%	0.024%
8/13/2022	Quantbot Technologies LP	2,900	$51K	0.0%	N/A	0.004%
8/13/2022	Renaissance Technologies LLC	116,630	$2.09M	0.0%	N/A	0.159%
8/12/2022	Northern Trust Corp	190,510	$3.41M	0.0%	+11.9%	0.259%
8/12/2022	Virtus ETF Advisers LLC	6,551	$0.12M	0.0%	-26.3%	0.009%
8/12/2022	FMR LLC	6,826,574	$122.20M	0.0%	+163.1%	9.293%
8/12/2022	Franklin Resources Inc.	2,465,380	$44.13M	0.0%	+59.8%	3.356%
8/12/2022	Rhumbline Advisers	33,954	$0.61M	0.0%	+74.9%	0.046%
8/11/2022	UBS Group AG	3,851	$69K	0.0%	N/A	0.005%
8/11/2022	Alps Advisors Inc.	36,730	$0.66M	0.0%	-42.3%	0.050%
8/5/2022	State Board of Administration of Florida Retirement System	13,760	$0.25M	0.0%	N/A	0.019%
8/4/2022	TD Asset Management Inc.	46,333	$0.83M	0.0%	+23.7%	0.063%
8/3/2022	Atlas Venture Life Science Advisors LLC	8,968,305	$160.53M	26.8%	+9.3%	12.217%
7/29/2022	SG Americas Securities LLC	9,446	$0.17M	0.0%	N/A	0.013%
7/25/2022	Silverarc Capital Management LLC	105,476	$1.89M	0.6%	N/A	0.144%
7/19/2022	TCI Wealth Advisors Inc.	1,974	$35K	0.0%	N/A	0.003%
7/13/2022	ACG Wealth	1,772	$32K	0.0%	N/A	0.002%
6/30/2022	Amalgamated Bank	3,034	$30K	0.0%	N/A	0.004%
5/27/2022	Walleye Capital LLC	26,148	$0.26M	0.0%	N/A	0.042%
5/17/2022	Walleye Capital LLC	26,148	$0.26M	0.0%	N/A	0.042%
5/17/2022	RA Capital Management L.P.	6,060,090	$60.12M	1.3%	+22.0%	9.789%
5/16/2022	California State Teachers Retirement System	9,687	$96K	0.0%	+58.6%	0.016%
5/16/2022	Goldman Sachs Group Inc.	31,212	$0.31M	0.0%	+27.2%	0.050%
5/16/2022	Deerfield Management Company L.P. Series C	2,086,449	$20.70M	0.5%	-5.3%	3.368%
5/16/2022	State Street Corp	216,216	$2.15M	0.0%	+14.1%	0.349%
5/13/2022	Northern Trust Corp	170,299	$1.69M	0.0%	+64.3%	0.275%
5/13/2022	Charles Schwab Investment Management Inc.	104,034	$1.03M	0.0%	+36.6%	0.168%
5/13/2022	American International Group Inc.	11,294	$0.11M	0.0%	+92.7%	0.018%
5/13/2022	Vanguard Group Inc.	2,986,426	$29.63M	0.0%	-1.6%	4.821%
5/12/2022	BlackRock Inc.	1,162,916	$11.54M	0.0%	+54.6%	1.877%
5/12/2022	Rhumbline Advisers	19,408	$0.19M	0.0%	N/A	0.031%
5/12/2022	MetLife Investment Management LLC	15,573	$0.15M	0.0%	N/A	0.025%
5/11/2022	Bank of New York Mellon Corp	57,490	$0.57M	0.0%	+78.3%	0.093%
5/11/2022	JPMorgan Chase & Co.	20,951	$0.21M	0.0%	-59.7%	0.034%
5/5/2022	New York State Common Retirement Fund	19,410	$0.19M	0.0%	+139.6%	0.031%
2/15/2022	Adage Capital Partners GP L.L.C.	110,000	$1.85M	0.0%	+22.2%	0.178%
2/14/2022	Virtus ETF Advisers LLC	9,413	$0.16M	0.1%	N/A	0.015%
2/14/2022	Deerfield Management Company L.P. Series C	2,202,533	$37.11M	0.8%	+28.7%	3.557%
2/14/2022	Summit Rock Advisors LP	33,125	$0.56M	0.3%	N/A	0.053%
2/14/2022	HarbourVest Partners LLC	13,388	$0.23M	0.0%	N/A	0.022%
2/10/2022	Pathway Capital Management LP	242,245	$4.08M	19.6%	N/A	0.391%
2/10/2022	TD Asset Management Inc.	37,449	$0.63M	0.0%	+122.2%	0.060%
2/9/2022	Alps Advisors Inc.	71,668	$1.21M	0.0%	N/A	0.116%
2/8/2022	ProShare Advisors LLC	11,127	$0.19M	0.0%	N/A	0.018%
2/8/2022	Northern Trust Corp	103,677	$1.75M	0.0%	+5.7%	0.167%
2/3/2022	Canaan Partners XI LLC	9,663,645	$162.83M	41.9%	N/A	15.604%
2/2/2022	New York State Common Retirement Fund	8,102	$0.14M	0.0%	N/A	0.013%
12/3/2021	Perceptive Advisors LLC	556,047	$13.20M	0.2%	-26.5%	0.898%
11/16/2021	Janus Henderson Group PLC	1,022,483	$23.38M	0.0%	-21.2%	1.651%
11/16/2021	Metropolitan Life Insurance Co NY	3,636	$86K	0.0%	N/A	0.006%
11/16/2021	Millennium Management LLC	177,945	$4.22M	0.0%	N/A	0.287%
11/16/2021	BVF Inc. IL	810,284	$19.23M	0.8%	-11.8%	1.308%
11/15/2021	Deerfield Management Company L.P. Series C	1,710,730	$40.60M	0.8%	+108.9%	2.762%
11/15/2021	Rock Springs Capital Management LP	376,439	$8.93M	0.2%	+0.7%	0.608%
11/15/2021	Viking Global Investors LP	1,211,396	$28.75M	0.1%	-9.7%	1.956%

Data available starting January 2016

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

Today's Range

Now: $21.45

$21.38

$22.06

50 Day Range

MA: $21.31

$19.34

$23.41

52 Week Range

Now: $21.45

$5.44

$28.35

Volume

263,007 shs

Average Volume

641,030 shs

Market Capitalization

$1.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top insider investors include:
Ai Day1 Llc (Major Shareholder)
Julie Papanek Grant (Director)
Xi LP Canaan (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Michael Gladstone (Director)
Papanek Julie Grant (Director)
Charles N York II (CFO)
Pharmaceutical Co Ltd Takeda (Major Shareholder)
Venture Fund Xi LP Atlas (Major Shareholder)
Learn More about top insider investors at Day One Biopharmaceuticals.